Asta Medica, Aktiengesellschaft

Degussa Aktiengesellschaft

Degussa Gmbh

Zentaris Ag

Eckhard Milsmann

Dieter Sauerbier

Jurgen Engel

Peter Hilgard

Otto Isaac

Thomas Klenner

Werner Sarlikiotis

Juergen Engel

Klaus Molge

The present invention relates to new solid pharmaceutical compositions containing hexadecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis, a process for the manufacture of said pharmaceutical composition, a dosage scheme for oral administration of said pharmaceutical composition in the treatment of leishmaniasis, and finally a combination comprising said solid pharmaceutical composition, antiemeticum, and/or an antidiarrhoeal.

Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis

A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain:

Tablet containing mesna as active substance and method of making same

Tablets and granulates containing mesna as active substance

A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain

Solid oral ifosfamide formulations comprising a capsule containing a mass which consists essentially of the active substance ifosfamide and microcrystalline cellulose, or in the form of tablets which contain, in relation to one part by weight of ifosfamide,

Solid oral dosage forms of ifosfamide

Growing community of inventors

Bielefeld, Germany

Eckhard Milsmann